Examining the Effect of Metaverse-based Epilepsy Education on Parents' Knowledge LevelNCT06195020
Examining the Effect of Metaverse-Based Epilepsy Education
A study testing Metaverse and Polyclinic information in people with Examining the Effect of Metaverse-based Epilepsy Education on Parents' Knowledge Level, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).
Trial summary
The research is a randomized controlled experimental study and was planned to examine the effect of metaverse-based epilepsy education on the epilepsy knowledge level of parents. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Examining the Effect of Metaverse-based Epilepsy Education on Parents' Knowledge Level
- What is being tested?
- Metaverse and Polyclinic information
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Jan 2024to Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Must be able to use a smartphone with internet access
- Having a child diagnosed with epilepsy
Who cannot join
- Having an additional chronic disease (diabetes, chronic kidney failure, cancer, etc.) other than epilepsy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Examining the Effect of Metaverse-Based Epilepsy Education on Parents' Epilepsy Knowledge Level: Randomized Controlled Experimental Research
The research is a randomized controlled experimental study and was planned to examine the effect of metaverse-based epilepsy education on the epilepsy knowledge level of parents.
Read the detailed description
Developments in the field of technology, patient density in polyclinic services, limited number of nurses specialized in the field and the desire to carry out effective workforce planning bring different education methods to the agenda in the field of nursing. Creating the metaverse universe, which has been used in many technological fields in recent years, is among the newest of these technological developments. When the content created in Metaverse-based training is presented to the user, the user has the opportunity to enter the universe, choose the avatar the participant wants, and navigate and gain information by entering the desired module among the training modules created for participant. At the same time, since it offers an interactive training module to the participant, there are no limitations such as time, place or subject as in other training models. When the literature was examined, no study was found in which metaverse-based education was used in the field of epilepsy. In this context, our research aimed to examine the usability of metaverse-based epilepsy education and its effect on parents' epilepsy knowledge level.
- Being tested
- Metaverse, Polyclinic information
- Keywords
- Epilepsy, metaverse, parent, knowledge level
- Medical subject headings
- Epilepsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MetaverseOther
The research consists of two stages (preparation and implementation). In the first stage of the research, the educational material planned to be used in the education of parents (video of navigation in the metaverse) will be developed in the form of modules. The topics in the training materials to be developed are listed below.
Module 1: Information about Epilepsy (What is epilepsy?, What are the causes of epilepsy? Module 2 Diagnostic Methods in Epilepsy (Neurological examination, blood tests, electroencephalogram, screening tests 3rd Module Treatment of Epilepsy (Things to consider in patients receiving antiepileptic drug therapy) Module 4: First Aid in Epilepsy (first aid in seizures with convulsions, first aid in seizures without convulsions) Module 5: Life with Epilepsy (Epilepsy and school, epilepsy and career choice, epilepsy and home safety, epilepsy and exercise, epilepsy and healthy nutrition, epilepsy and sleep) The intervention will last 3 months.
Polyclinic informationOther
This group will be informed only at the outpatient clinic. The intervention will last 3 months.
| Study group | Role | What they receive |
|---|---|---|
| Experimental Group | Experimental | This group will be informed by sharing and using educational videos prepared in the Metaverse universe on mobile. Receives: Other: Metaverse |
| Control Group | Active comparator | This group will be informed through routine outpatient clinic service. Receives: Other: Polyclinic information |
What is being measured
The primary outcome is the main question the study is designed to answer.
Introductory Form Regarding Parents and the Child's Illness
This form consists of 9 questions and includes descriptive characteristics of the parents (age, mother/father, education level) and information about the epilepsy disease (mother/father age, educational status, occupation, diagnosis). questions (time, medications used, sources of information about the disease).
Measured: 3 months
Epilepsy Knowledge Test Developed for Parents
This test, developed by researchers in line with the literature, consists of 50 questions. Answers to each test question can be given as "true", "false" or "I don't know".
Measured: 3 months
Secondary outcomes (2)
Application Content and Quality Evaluation by the Expert Group [DISCERN Measurement Tool (Quality of Criteria for Consumer Health Information)]
The DISCERN measurement tool was developed by Charnock et al. (1999) to be used in evaluating the content and quality of the educational material. The DISCERN measurement tool, which consists of three parts, contains 16 questions that question the content of the material. The first part, consisting of eight questions, measures the reliability of the material, the second part, consisting of seven questions, measures the quality of the information provided on treatment/care options, while the third part, consisting of a single question, questions the general evaluation of the material. In DISCERN, each question is scored from 1 to 5, where "5" indicates the suitability of the material and "1" indicates the inappropriateness of the material. By summing the responses from each item, a score between 15 and 75 is obtained. Article 16, which gives the general evaluation, is evaluated separately.
Measured: 3 months
System Usability Scale (SUS)
This measurement tool will be applied to parents in evaluating the usability of the developed universe. Created by John Brooke in 1986, this scale allows evaluation of a wide range of products and services, including hardware, software, mobile devices, websites and applications. Five-point Likert-type scale consisting of 10 items. The scale consists of 10 items and has a 5-point Likert-type evaluation (0: strongly disagree, 1: disagree, 2: undecided, 3: agree, 4: strongly agree). Items 2, 4, 6, 8 and 10 in the scale are scored in reverse, and the score obtained from each participant is multiplied by 2.5 to obtain a score between 0-100. Based on research, an SUS score above 68 is considered above average and any score below 68 is considered below average (https://www.usability.gov/how-to-and-tools/methods/system-usability -scale.html Access Date: 28.02.2021).
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2024
- Study startJan 2024 (estimated)
- Primary completionMar 2024 (estimated)
- Study completionJun 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Examining the Effect of Metaverse-based Epilepsy Education on Parents' Knowledge LevelStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Suleyman Demirel University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehmet Duray, Suleyman Demirel University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06195020
- Sponsor's protocol ID
- 72867572-050.01.04
- Status last verified
- Jan 2024
- First submitted
- 21 Dec 2023
- Last updated
- 8 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining the Effect of Metaverse-Based Epilepsy Education on Parents' Epilepsy Knowledge Level: Randomized Controlled Experimental Research
- ClinicalTrials.gov ID
- NCT06195020
- Acronym / sponsor ID
- 72867572-050.01.04
- Keywords
- Epilepsy, metaverse, parent, knowledge level
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Suleyman Demirel UniversityUniversity, hospital or other
- Study start
- Jan 2024 (estimated)
- Primary completion
- Mar 2024 (estimated)
- Study completion
- Jun 2024 (estimated)
- First posted
- 8 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The research is a randomized controlled experimental study and was planned to examine the effect of metaverse-based epilepsy education on the epilepsy knowledge level of parents.
Detailed description
Developments in the field of technology, patient density in polyclinic services, limited number of nurses specialized in the field and the desire to carry out effective workforce planning bring different education methods to the agenda in the field of nursing. Creating the metaverse universe, which has been used in many technological fields in recent years, is among the newest of these technological developments. When the content created in Metaverse-based training is presented to the user, the user has the opportunity to enter the universe, choose the avatar the participant wants, and navigate and gain information by entering the desired module among the training modules created for participant. At the same time, since it offers an interactive training module to the participant, there are no limitations such as time, place or subject as in other training models. When the literature was examined, no study was found in which metaverse-based education was used in the field of epilepsy. In this context, our research aimed to examine the usability of metaverse-based epilepsy education and its effect on parents' epilepsy knowledge level.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental Group | Experimental | Other: MetaverseThis group will be informed by sharing and using educational videos prepared in the Metaverse universe on mobile. |
| Control Group | Active comparator | Other: Polyclinic informationThis group will be informed through routine outpatient clinic service. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Must be able to use a smartphone with internet access
- Having a child diagnosed with epilepsy
Key exclusion criteria (1 listed)
- Having an additional chronic disease (diabetes, chronic kidney failure, cancer, etc.) other than epilepsy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MetaverseThe research consists of two stages (preparation and implementation). In the first stage of the research, the educational material planned to be used in the education of parents (video of navigation in the metaverse) will be developed in the form of modules. The topics in the training materials to be developed are listed below. Module 1: Information about Epilepsy (What is epilepsy?, What are the causes of epilepsy? Module 2 Diagnostic Methods in Epilepsy (Neurological examination, blood tests, electroencephalogram, screening tests 3rd Module Treatment of Epilepsy (Things to consider in patients receiving antiepileptic drug therapy) Module 4: First Aid in Epilepsy (first aid in seizures with convulsions, first aid in seizures without convulsions) Module 5: Life with Epilepsy (Epilepsy and school, epilepsy and career choice, epilepsy and home safety, epilepsy and exercise, epilepsy and healthy nutrition, epilepsy and sleep) The intervention will last 3 months. | Other | Experimental Group |
| Polyclinic informationThis group will be informed only at the outpatient clinic. The intervention will last 3 months. | Other | Control Group |
Primary outcome
Introductory Form Regarding Parents and the Child's Illness
Time frame: 3 months
This form consists of 9 questions and includes descriptive characteristics of the parents (age, mother/father, education level) and information about the epilepsy disease (mother/father age, educational status, occupation, diagnosis). questions (time, medications used, sources of information about the disease).
Epilepsy Knowledge Test Developed for Parents
Time frame: 3 months
This test, developed by researchers in line with the literature, consists of 50 questions. Answers to each test question can be given as "true", "false" or "I don't know".
2 secondary outcomes
Application Content and Quality Evaluation by the Expert Group [DISCERN Measurement Tool (Quality of Criteria for Consumer Health Information)]
Time frame: 3 months
System Usability Scale (SUS)
Time frame: 3 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2024.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Metaverse and Polyclinic information in people with Examining the Effect of Metaverse-based Epilepsy Education on Parents' Knowledge Level, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact MEHMET DURAY (02462113268, mehmetduray@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Introductory Form Regarding Parents and the Child's Illness (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2024.